By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has invested $5 million in molecular diagnostics firm CardioDx as part of a Series D round of financing for the startup.

GE Healthcare also said that it has formed an alliance with the Palo Alto, Calif.-based firm to co-develop diagnostic technologies for the care and management of patients with cardiovascular disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.